Home Medicine Occult inflammation and/or ischemia may be responsible for the false positivity of biochemical Down syndrome screening test
Article
Licensed
Unlicensed Requires Authentication

Occult inflammation and/or ischemia may be responsible for the false positivity of biochemical Down syndrome screening test

  • , , , , and
Published/Copyright: March 18, 2010
Journal of Perinatal Medicine
From the journal Volume 38 Issue 4

Abstract

Objective: To determine the possible underlying cause of a false-positive first or second trimester biochemical Down syndrome screening test result by means of second trimester amniotic fluid cytokine level analysis.

Methods: A total of 74 consecutive patients undergoing amniocentesis for karyotype analysis at 16–20 weeks' gestation were included in this prospective age-matched case-control study. The study group (n=38) had abnormal first or second trimester screening test results and normal karyotype results, while controls (n=36) included those admitted for genetic amniocentesis for other reasons who had normal first or second trimester screening test and normal karyotype results. Four markers [interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α, and ischemia-modified albumin (IMA)] were studied in amniotic fluid.

Results: The mean age of the women in the study and control groups was 34.0±5.6 and 33.6±7.2 years, respectively. The women in the study and control groups had similar clinical and laboratory characteristics. The mean amniotic fluid IL-6 (414.84±83.96 vs. 343.02±110.59, p=0.002) and IL-8 (377.61±243.31 vs. 261.90±201.29, p=0.029), TNF-α (24.91±5.78 vs. 21.60±5.55, p=0.014), and IMA (1.19± 0.10 vs. 1.05±0.12, p<0.001) values were significantly increased in the study group when compared to controls.

Conclusion: The higher amniotic fluid cytokine and ischemia-modified albumin levels in patients with false-positive first or second trimester biochemical Down syndrome screening test may result from subclinical fetal membrane inflammation and/or ischemia.


Corresponding author: Suleyman Guven, MD KTÜ Tıp Fakültesi, Farabi Hastanesi Kadın Hastalıkları ve Doğum ABD 61080 Trabzon Turkey Tel.: + (462) 377 58 69 Fax: + (462) 325 05 18

Received: 2009-8-29
Revised: 2010-1-7
Accepted: 2010-1-12
Published Online: 2010-03-18
Published Online: 2010-03-18
Published in Print: 2010-07-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Recommendations and guidelines for perinatal practice
  2. Donor human milk in preterm infant feeding: evidence and recommendations
  3. Original articles – Obstetrics
  4. Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003–2008
  5. Maternal plasma retinol binding protein 4 in acute pyelonephritis during pregnancy
  6. Occult inflammation and/or ischemia may be responsible for the false positivity of biochemical Down syndrome screening test
  7. Genital group B streptococcus carrier rate and serotype distribution in Korean pregnant women: implications for group B streptococcal disease in Korean neonates
  8. Pregnancy-induced antithrombin deficiency
  9. Cardiac output and blood flow volume redistribution during acute maternal hypoxia in fetal sheep
  10. Original articles – Fetus
  11. Epigenetic malprogramming of the insulin receptor promoter due to developmental overfeeding
  12. Prognosis of isolated mild to moderate fetal cerebral ventriculomegaly: a systematic review
  13. Original articles – Newborn
  14. Validation of a model to predict hospitalization due to RSV of infants born at 33–35 weeks' gestation
  15. Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure
  16. Dependence of neonatal small and large for gestational age rates on maternal height and weight – an analysis of the German Perinatal Survey
  17. Clinical characteristics of nosocomial infections in neonatal intensive care unit in eastern China
  18. Short Communication
  19. Maternal complications of fetoscopic laser photocoagulation (FLP) for treatment of twin-twin transfusion syndrome (TTTS)
  20. Letter to the Editor
  21. A newborn with Down syndrome-transient myeloproliferative disorder
  22. Congress Calender
  23. Congress Calendar
  24. WAPM-Newsletter
  25. WAPM-Newsletter No 1/2010
Downloaded on 1.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpm.2010.062/html
Scroll to top button